Methyl-orvinol—Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome

[1]  J. Fichna,et al.  Mixed MOP/DOP agonist biphalin elicits anti-transit effect in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms , 2016, Pharmacological reports : PR.

[2]  W. Krajewska,et al.  Orally administered novel cyclic pentapeptide P‐317 alleviates symptoms of diarrhoea‐predominant irritable bowel syndrome , 2015, The Journal of pharmacy and pharmacology.

[3]  R. Kale,et al.  Antidiarrheal activity of ethanolic extract of Manihot esculenta Crantz leaves in Wistar rats , 2015, Journal of Ayurveda and integrative medicine.

[4]  J. Fichna,et al.  Anti-inflammatory and antinociceptive action of the dimeric enkephalin peptide biphalin in the mouse model of colitis: New potential treatment of abdominal pain associated with inflammatory bowel diseases , 2014, Peptides.

[5]  Maree T. Smith,et al.  Endomorphin analogues with mixed μ-opioid (MOP) receptor agonism/δ-opioid (DOP) receptor antagonism and lacking β-arrestin2 recruitment activity. , 2014, Bioorganic & medicinal chemistry.

[6]  R. Su,et al.  Effect of thienorphine on intestinal transit and isolated guinea-pig ileum contraction. , 2013, World journal of gastroenterology.

[7]  Mark P Thomas,et al.  Orvinols with Mixed Kappa/Mu Opioid Receptor Agonist Activity , 2013, Journal of medicinal chemistry.

[8]  J. Fichna,et al.  Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives , 2013, Journal of Gastroenterology.

[9]  C. Schneider,et al.  Modulation of gastrointestinal function by MuDelta, a mixed µ opioid receptor agonist/ µ opioid receptor antagonist , 2012, British journal of pharmacology.

[10]  Saleha Akter,et al.  Antinociceptive, antidiarrheal, and neuropharmacological activities of Barringtonia acutangula , 2012, Pharmaceutical biology.

[11]  Z. Gong,et al.  TH-030418: a potent long-acting opioid analgesic with low dependence liability , 2011, Naunyn-Schmiedeberg's Archives of Pharmacology.

[12]  D. Drossman,et al.  Functional Bowel Disorders , 1995, The American Journal of Gastroenterology.

[13]  A. Janecka,et al.  Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating κ‐opioid and cannabinoid receptors , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[14]  P. Holzer.  Opioid receptors in the gastrointestinal tract , 2009, Regulatory Peptides.

[15]  N. Hyland,et al.  The regulation of veratridine‐stimulated electrogenic ion transport in mouse colon by neuropeptide Y (NPY), Y1 and Y2 receptors , 2005, British journal of pharmacology.

[16]  Bao-Hua Liu,et al.  Effects of mu and kappa opioid receptor agonists and antagonists on contraction of isolated colon strips of rats with cathartic colon. , 2004, World journal of gastroenterology.

[17]  S. Husbands,et al.  The orvinols and related opioids--high affinity ligands with diverse efficacy profiles. , 2004, Current pharmaceutical design.

[18]  M. Fromm,et al.  Antisecretory effect of loperamide in colon epithelial cells by inhibition of basolateral K+ conductance. , 2001, Scandinavian journal of gastroenterology.

[19]  J. Cassel,et al.  Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity. , 1999, The Journal of pharmacology and experimental therapeutics.

[20]  N. Joo,et al.  Regulation of intestinal Cl- and[Formula: see text] secretion by uroguanylin. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[21]  N. Joo,et al.  Regulation of intestinal Cl- and[Formula: see text] secretion by uroguanylin. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[22]  R. D. D'Souza,et al.  Gastrointestinal actions of buprenorphine: are different receptors involved? , 1996, European journal of pharmacology.

[23]  A. De Luca,et al.  Insights into opioid action in the intestinal tract. , 1996, Pharmacology & therapeutics.

[24]  T. Gaginella,et al.  Dissociation of castor oil‐induced diarrhoea and intestinal mucosal injury in rat: effect of NG‐nitro‐L‐arginine methyl ester , 1994, British journal of pharmacology.

[25]  K. W. Bentley,et al.  Novel analgesics and molecular rearrangements in the morphine-thebaine group. 3. Alcohols of the 6,14-endo-ethenotetrahydrooripavine series and derived analogs of N-allylnormorphine and -norcodeine. , 1967, Journal of the American Chemical Society.